HCPLive Network

Simple Reminder Form Increases Pneumococcal Vaccination Rate

 
TUESDAY, Jan. 22 (HealthDay News) -- Use of a simple point-of-care paper reminder form is associated with an increase in the percentage of immunosuppressed rheumatology patients who remain up-to-date with their pneumococcal vaccinations, according to research published in the January issue of Arthritis & Rheumatism.

Sonali P. Desai, M.D., M.P.H., of the Brigham and Women's Hospital in Boston, and colleagues evaluated the effects of a quality improvement strategy involving a paper point-of-care reminder form designed to increase the percentage of immunosuppressed patients who kept up-to-date with pneumococcal vaccination, in a rheumatology practice. The cohort included 3,717 patients who were taking immunosuppressive medications (66.0 percent with rheumatoid arthritis; 74.1 percent women).

The researchers found that, in the time period following the intervention, there was a significant increase in the rate of patients who were up-to-date with pneumococcal vaccination for rheumatologists in the intervention (67.6 to 80.0 percent), compared with a stable rate among rheumatologists in the nonintervention control (52.3 to 52.0 percent). Positive predictors of receiving the appropriate vaccinations including having received the intervention (hazard ratio [HR], 3.58), having a primary care physician affiliated with Brigham and Women's Hospital (HR, 1.68), having a diagnosis of diabetes mellitus (HR, 1.57), and being 56 to 65 years of age at baseline (HR, 1.24).

"It is possible to significantly increase vaccination for an important at-risk immunosuppressed patient population through the use of a simple point-of-care reminder," the authors write. "Future efforts should continue to study and test quality improvement methods in order to effect sustained change."

One author disclosed financial ties to the pharmaceutical industry and UpToDate.
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
The US Food and Drug Administration (FDA) approved today Xtoro (finafloxacinotic suspension), a novel drug treatment for acute otitis externa, otherwise known as swimmer’s ear, an infection within the outer ear and ear canal, typically caused by bacteria festered in the ear canal.
A support group developed by a hospital in New York has shown that patients with rheumatoid arthritis can see their condition improve by not only addressing the physical symptoms but the psychological issues as well.
Capitalizing on the infatuation many parents-to-be have with their babies-to-be, commercial enterprises are making and selling “keepsake “ ultrasound images. In a related trend, some consumers are purchasing Doppler ultrasound heartbeat monitors over the counter and without the required prescription for their use.
More Reading